1-Methoxy-4-(methylsulfinyl)benzene, 97%, 25g

5-Methyl-3-nitroimidazo[1,2-a]pyridine, 95.0%, 1g

1,2,3,4-tetrahydro-1,6-naphthyridin-8-amine, 95.0%, 1g

4-(N-(4-Chlorophenyl)sulfamoyl)benzoic acid, 97%, 250mg

Tetraethylammonium Tetrafluoroborate>98.0%(N)5g

5-Bromo-4-fluoro-1-methyl-1H-indazole, 25g

Sodium 3-(Trimethylsilyl)-1-propanesulfonate [1H NMR Standard for D2O Solvent]>98.0%(T)1g

4-Chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, 95.0%, 100mg

Axitinib>95.0%(HPLC)(T)50mg

(2E)-1-(4-bromophenyl)-3-(4-ethoxyphenyl)prop-2-en-1-one, 95.0%, 10g

3-Bromo-2-fluoro-5-methyl pyridine, 98.0%, 25g

1-tert-Butyl 3-ethyl 3-cyanoazetidine-1,3-dicarboxylate, 95.0%, 1g

Benzyltriethoxysilane>96.0%(GC)25g